Lexicon Pharmaceuticals, Inc. is downgraded to Hold due to repeated FDA rejections of ZYNQUISTA for T1D and catalysts. Read more on LXRX stock here.

Droughts have been known to reduce overdose deaths. For example, Australia experienced a significant “heroin drought” in 2001 ...

FDA has previously agreed on the design of this 300-patient randomized, placebo-controlled confirmatory Phase 3 trial, and the 12-month primary endpoint of pain reduction as an approvable indication.

Many jails and prisons around the country don't provide medication treatment for opioid use disorder. Studies show that ...

U.S. overdose deaths fell through the most of last year, suggesting a lasting improvement in an epidemic that had been ...

Opioid abuse during pregnancy is on the rise, new research suggests—and that’s likely to endanger both expectant mothers and their children. Researchers at Oregon Health & Science University (OHSU) ...

Prescriptions for the new non-opioid pain medication suzetrigine more than doubled between April and August 2025, according to analysis from Epic Research. The increase indicates a growing interest in ...

TUCSON, Ariz. (13 News) - A new fentanyl crisis is emerging across the country and in our own backyard. Overdose deaths are surging among one group: older adults. The newest numbers show more than a 1 ...

From 2023 to 2025, Tennessee’s 95 counties received $86.8M in opioid abatement funds. The state has paused public reporting on how the funds are being spent as it works on a new tracking system. Drug ...

President Donald Trump has repeatedly claimed that military strikes on suspected drug boats his administration has been carrying out for more than two months in the Caribbean Sea and Pacific Ocean are ...

A federal bankruptcy court judge on Tuesday formally approved OxyContin maker Purdue Pharma’s plan to settle thousands of lawsuits over the harms of opioids. U.S. Bankruptcy Judge Sean Lane gave ...